Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Zug, Switzerland, May 4, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, April 20, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
-
Zug, Switzerland, March 30, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedi-cated to developing therapeutics that address important unmet medical needs in...
-
Zug, Switzerland, March 19, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the fourth quarter and financial...
-
ZUG, Switzerland, March 16, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (Nasdaq:EARS) today announced that it will release its financial results for the fourth quarter and full year 2014, on...
-
Auris Medical AG: Auris Medical to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Thursday, March 19, 2015 Zug, Switzerland, March 16, 2015 - Auris Medical...
-
Zug, Switzerland, March 13, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
-
Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City
Zug, Switzerland, March 11, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
-
Zug, Switzerland, March 10, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
-
Zug, Switzerland, February 11, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...